Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
about
Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?A multicenter observational safety study in Swedish children and adolescents using insulin detemir for the treatment of type 1 diabetesDevelopment of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years.An update on the pharmacotherapy options for pediatric diabetes.Effect of combined application insulin and insulin detemir on continous glucose monitor in children with type 1 diabetes mellitusLong-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.
P2860
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
@ast
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
@en
type
label
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
@ast
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
@en
prefLabel
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
@ast
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
@en
P2093
P2860
P356
P1433
P1476
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
@en
P2093
P2860
P304
P356
10.1111/DME.12041
P577
2013-02-01T00:00:00Z